xanthenes has been researched along with Disease Models, Animal in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.37) | 18.7374 |
1990's | 2 (2.74) | 18.2507 |
2000's | 23 (31.51) | 29.6817 |
2010's | 37 (50.68) | 24.3611 |
2020's | 10 (13.70) | 2.80 |
Authors | Studies |
---|---|
Bartoszek, A; Binienda, A; Dziedziczak, K; Fabisiak, A; Fichna, J; Kordek, R; Krajewska, JB; Makaro, A; Mosińska, P; Niewinna, K; Salaga, M; Świerczyński, M; Talar, M; Tarasiuk, A | 1 |
Ciapała, K; Kwiatkowski, K; Makuch, W; Mika, J; Pawlik, K; Piotrowska, A; Popiolek-Barczyk, K | 1 |
Hoshino, T; Matsuzawa, SI; Takahashi, R | 1 |
Campos, MM; Costa, KM; da Costa, JC; Dagnino, APA; Freitas, RDS; Greggio, S; Muradás, TC; Rost, FL; Venturin, GT | 1 |
Alarabi, AB; Ali, HEA; Alshbool, FZ; Hernandez, KR; Hinojos, V; Karim, ZA; Khasawneh, FT; Lozano, PA; Montes Ramirez, JE | 1 |
Gong, YF; Huang, TY; Huang, XY; Liu, XC; Wang, ZZ; Zhang, XM | 1 |
Pałucha-Poniewiera, A; Podkowa, K; Rafało-Ulińska, A | 1 |
Ding, Z; Jing, F; Li, Y; Lu, B; Song, X; Tang, Z; Wu, H | 1 |
Kang, H; Kim, KJ; Lee, J; Lee, Y; Oh, E; Park, C; Park, KH; Son, YJ; Wang, W; Woo, GE | 1 |
Jing, XY; Li, LF; Li, ZL; Liu, YJ; Wang, Y; Zou, HW | 1 |
Atanasov, AG; Breuss, JM; Dirsch, VM; Heiss, EH; Jiang, B; Liu, R; Liu, W; Schachner, D | 1 |
Blaxall, BC; Kamal, FA; Lorenz, JN; Molkentin, JD; Nieman, ML; Sargent, MA; Travers, JG; Valiente-Alandi, I | 1 |
Ito, Y; Kariya, T; Maruyama, S; Matsukawa, Y; Mizuno, M; Nishimura, H; Sakata, F; Suzuki, Y; Takei, Y | 1 |
Li, G; Liu, Y; Yan, D; Zhang, H; Zhang, Y; Zhao, L | 1 |
Ikutomo, M; Muramatsu, K; Niwa, M; Shimo, S; Tamaki, T | 1 |
Kreiner, G; Mika, J; Nalepa, I; Piotrowska, A; Rojewska, E; Zychowska, M | 1 |
Chaki, S; Iijima, M; Koike, H | 3 |
Hara, T; Ide, S; Kaneda, K; Koseki, K; Maruyama, C; Minami, M; Naka, T; Ohno, A; Tamano, R; Yoshioka, M | 1 |
Baamonde, A; Hidalgo, A; Lastra, A; Meana, Á; Menéndez, L; Pevida, M | 1 |
Bin, L; Cheng, P; Dong, C; Fenggen, Y; Guanghui, W; Hui, C; Jingjing, S; Mei, W; Meiling, S; Qinglin, L; Xiaoshan, W; Yawen, H; Zhiwu, C | 1 |
Chan, MH; Chen, HH; Chiang, CC; Chiu, HY; Lee, MY | 1 |
Blaxall, BC; Hammes, SR; Kamal, FA; Mickelsen, DM; Moalem, J; Smrcka, AV; Travers, JG; Wegman, KM | 1 |
Chaki, S; Koike, H | 1 |
Diao, Y; Li, H; Li, X; Shan, L; Wang, H; Yin, J; Yue, R; Zhang, J; Zhang, S; Zhang, W | 1 |
Bai, G; Cao, DY; Ji, Y; Traub, RJ | 1 |
Benn, A; Robinson, ES | 1 |
Dong, W; Ji, X; Liang, J; Liu, KJ; Luo, Y; Qi, Z; Shi, W; Zhao, Y | 1 |
Ago, Y; Hasebe, S; Hashimoto, H; Matsuda, T; Nishiyama, S; Oka, S; Onaka, Y; Takuma, K | 1 |
Filipek, B; Gałuszka, A; Kazek, G; Kij, A; Marona, H; Olczyk, A; Pytka, K; Rapacz, A; Sapa, J; Siwek, A; Walczak, M; Waszkielewicz, A | 1 |
Altamirano, J; Borja-Villa, C; García, N; Pérez-Treviño, J; Pérez-Treviño, P | 1 |
Awasthi, S; Bossuyt, J; Chan, JW; Chen, YJ; Chen-Izu, Y; Chiamvimonvat, N; Izu, LT; Jian, Z; Lam, KS; Landas, T; Lerner, A; Lieu, DK; Mao, Z; Matthews, DL; Shimkunas, R; Woldeyesus, R; Wood, BM | 1 |
Andrade, PB; Guedes-Dias, P; Leitão-Rocha, A; Oliveira, JM; Pinho, BR; Quintas, C; Reis, SD; Santos, MM; Valentão, P | 1 |
Baamonde, A; Fernández-García, MT; González-Rodríguez, S; Hidalgo, A; Lastra, A; Llorián-Salvador, M; Menéndez, L | 1 |
Basta-Kaim, A; Budziszewska, B; Głombik, K; Holst, B; Młyniec, K; Nowak, G; Siwek, A; Skrzeszewski, J; Ślusarczyk, J; Trojan, E | 1 |
Feng, GH; Gao, LH; Li, L; Liu, HY; Liu, J; Liu, X; Niu, Y | 1 |
Connolly, KL; Detrick, MS; Horzempa, J; Jerse, AE; Schmitt, DM | 1 |
Ali, I; Amhaoul, H; Boets, S; Dedeurwaerdere, S; Janssens, P; Langlois, X; Van Eetveldt, A | 1 |
Egashira, T; Fukuda, K; Hashimoto, H; Hayashi, K; Hayashiji, N; Ito, S; Kashimura, S; Kodaira, M; Kunitomi, A; Kusumoto, D; Lachmann, M; Motoda, C; Nagai, T; Nakanishi, C; Sakata, K; Seki, T; Shimojima, M; Takei, M; Tohyama, S; Yamagishi, M; Yozu, G; Yuasa, S | 1 |
Arcella, A; Battaglia, G; Carpinelli, G; Ciceroni, C; De Maria, R; Giangaspero, F; Mastrantoni, E; Melchiorri, D; Mosillo, P; Nicoletti, F; Oliva, MA; Pallini, R; Ricci-Vitiani, L; Sale, P; Santoro, F | 1 |
Flannery, JG; Gregory-Evans, CY; Gregory-Evans, K; Guerin, K; Hodges, MD; Mackay, DS; Moosajee, M | 1 |
Steketee, JD; Xie, X | 1 |
Bianchi, E; Ghelardini, C; Norcini, M; Smrcka, A | 1 |
Bittner, GD; Boydston, EA; Britt, JM; Estler, CJ; Gbanaglo, MY; Kane, JR; Robinson, GL; Schallert, T; Spaeth, CS; Zuzek, A | 1 |
Bengtsen, CH; Christiansen, SH; Dencker, D; Fink-Jensen, A; Jensen, M; Loland, CJ; Petersen, JH; Sørensen, G; Weikop, P; Woldbye, DP; Wörtwein, G | 1 |
Almaguer-Villagrán, L; Arce-Paredes, P; Cid-Gutiérrez, JL; Jiménez-Arellanes, A; Mendoza-Aguilar, M; Rojas-Espinosa, O | 1 |
Bojang, P; Furukawa, T; Goldberg, AF; Gregg, RG; Hirschtritt, ME; Koike, C; McCall, MA; Nawy, S; Nishina, PM; Peachey, NS; Pearring, JN; Ray, TA; Shen, Y; Sturgill-Short, G | 1 |
Cole, ST; Dhar, N; Hartkoorn, RC; Mendoza-Losana, A; Sala, C; Zhang, M | 1 |
Aston-Jones, G; Fallon, RV; Hensley-Simon, M; Kalivas, PW; LaLumiere, RT; Mahler, SV; Tahsili-Fahadan, P; Thomas, C | 1 |
Chaki, S; Fukumoto, K; Iijima, M; Koike, H | 1 |
Mitsumoto, Y; Mori, A; Nakai, M; Watanabe, A | 1 |
Anderson, JJ; Baccei, CS; Bristow, LJ; Campbell, UC; Correa, LD; Lorrain, DS; Pinkerton, AB; Rodriguez, DE; Rowe, B; Schaffhauser, H; Varney, MA; Vernier, JM | 1 |
Chopin, C; Depontieu, F; Lancel, S; Marechal, X; Mordon, S; Neviere, R; Scherpereel, A; Tissier, S | 1 |
Grajkowska, E; Hirasawa, S; Kozikowski, A; Neale, JH; Wroblewska, B; Wroblewski, J; Yamamoto, T; Zhou, J | 1 |
Achilefu, S | 1 |
Ding, J; Fan, Y; Geng, M; Hu, J; Li, J; Wang, J; Xin, X; Yang, Z | 1 |
Bolwig, TG; Ernfors, P; Husum, H; Kokaia, M; Nanobashvili, A; Sørensen, AT; Sørensen, G; Woldbye, DP | 1 |
Battaglia, G; Biagioni, F; Bruno, V; Casciato, S; Ngomba, RT; Nicoletti, F; van Luijtelaar, EL; Willems-van Bree, E | 1 |
Ebinger, G; Hachimi-Idrissi, S; Michotte, Y; Sarre, S; Van Hemelrijck, A | 1 |
Carta, M; Mameli, M; Valenzuela, CF | 1 |
Griffey, KI; Johnson, BG; Knitowski, KM; McKinzie, DL; Monn, JA; Perry, KW; Rorick-Kehn, LM; Salhoff, CR; Schoepp, DD; Tizzano, JP; Witkin, JM | 1 |
Chen, W; He, J; Leng, X; Liao, X; Liu, J; Ma, H; Mai, W; Tao, J; Wang, L; Zhen, W | 1 |
Girardi, P; Giusti, P; Gruber, SH; Iacovelli, L; Mathé, AA; Matrisciano, F; Nicoletti, F; Panaccione, I; Tatarelli, R; Zusso, M | 1 |
Baker, DA; Haroutunian, V; Kristiansen, LV; Madayag, A; Meador-Woodruff, JH; Raju, I | 1 |
Castellano, RK; Ferreira, AJ; Gubala, V; Hernández Prada, JA; Katovich, MJ; Lampkins, AJ; Ostrov, DA; Qi, Y; Raizada, MK; Santos, RA; Shenoy, V | 1 |
Algarra, I; Gaforio, JJ; Garrido, F; Höglund, P; Ljunggren, HG; Pérez, M | 1 |
Ichiki, H; Ishihara, E; Komatsu, Y; Kubo, M; Miura, T; Okada, M; Tanigawa, K | 1 |
Carlen, PL; Frantseva, MV; Hwang, PA; Velazquez, JL | 1 |
Hashimoto, I; Ichiki, H; Ishida, T; Ishihara, E; Iwamoto, N; Kato, M; Komatsu, Y; Kubo, M; Miura, T; Okada, M; Tanigawa, K | 1 |
Bringmann, A; Faude, F; Francke, M; Goczalik, I; Grosche, J; Milenkovic, I; Pannicke, T; Reichenbach, A; Uckermann, O; Uhlmann, S; Weick, M; Wiedemann, P | 1 |
Cai, Z; Lin, S; Rhodes, PG | 1 |
Lämmler, G; Rudolph, R; Schuster, J; Zahner, H | 1 |
2 review(s) available for xanthenes and Disease Models, Animal
Article | Year |
---|---|
Multimodal SHG-2PF Imaging of Microdomain Ca2+-Contraction Coupling in Live Cardiac Myocytes.
Topics: Aniline Compounds; Animals; Cardiomyopathies; Disease Models, Animal; Excitation Contraction Coupling; Fluorescent Dyes; Kinetics; Male; Mechanotransduction, Cellular; Membrane Microdomains; Mice; Microscopy, Confocal; Microscopy, Fluorescence, Multiphoton; Multimodal Imaging; Myocardial Contraction; Myocytes, Cardiac; Rats, Sprague-Dawley; Sarcomeres; Stress, Mechanical; Xanthenes | 2016 |
Lighting up tumors with receptor-specific optical molecular probes.
Topics: Animals; Bombesin; Carbocyanines; Carrier Proteins; Cell Membrane; Coloring Agents; Contrast Media; Diagnostic Imaging; Disease Models, Animal; Epidermal Growth Factor; Fluorescent Dyes; Folic Acid; Humans; Light; Models, Chemical; Models, Molecular; Molecular Probes; Neoplasms; Neurotensin; Peptides; Photosensitizing Agents; Somatostatin; Xanthenes | 2004 |
71 other study(ies) available for xanthenes and Disease Models, Animal
Article | Year |
---|---|
Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis.
Topics: Aniline Compounds; Animals; Butyrates; Colitis; Disease Models, Animal; Drug Synergism; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Inflammation; Ligands; Male; Mice; Mice, Inbred BALB C; Naloxone; Narcotic Antagonists; Peroxidase; Receptors, G-Protein-Coupled; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Sulfonamides; Thiophenes; Xanthenes | 2021 |
The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
Topics: Analgesics; Animals; Buprenorphine; Calcium-Binding Proteins; Chemokine CCL2; Disease Models, Animal; Drug Synergism; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Interleukin-18; Interleukin-1beta; Interleukin-6; Male; Microfilament Proteins; Morphine; Neuralgia; Nociception; Peroxidase; Protein Isoforms; Rats; Rats, Wistar; Receptors, CCR1; Sciatic Nerve; Signal Transduction; Xanthenes | 2020 |
6-Deoxyjacareubin, a natural compound preventing hypoxia-induced cell death, ameliorates neurodegeneration in a mouse model of familial amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Death; Disease Models, Animal; Hypoxia; Mice; Mice, Transgenic; Motor Neurons; Pyrans; Superoxide Dismutase; Superoxide Dismutase-1; Xanthenes | 2021 |
Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
Topics: alpha-Linolenic Acid; Animals; Benzoates; Biphenyl Compounds; Body Weight; Cachexia; Carcinoma, Lewis Lung; Disease Models, Animal; Docosahexaenoic Acids; Methylamines; Mice; Muscle, Skeletal; Neoplasm Transplantation; Phenylpropionates; Propionates; Pyrimidines; Receptors, G-Protein-Coupled; Sulfonamides; Xanthenes | 2020 |
The G-protein βγ subunits regulate platelet function.
Topics: Animals; Blood Platelets; Clot Retraction; Disease Models, Animal; GTP-Binding Protein beta Subunits; GTP-Binding Protein gamma Subunits; Hemostasis; Humans; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction; Thrombosis; Xanthenes | 2020 |
Scar-reducing effects of gambogenic acid on skin wounds in rabbit ears.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Anti-Inflammatory Agents; Cicatrix, Hypertrophic; Collagen; Cytokines; Disease Models, Animal; Ear; Female; Inflammation Mediators; Male; Neovascularization, Physiologic; Rabbits; Signal Transduction; Skin; Wound Healing; Wounds and Injuries; Xanthenes | 2021 |
The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
Topics: Amino Acids; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Hippocampus; Ketamine; Male; Mice; Mice, Inbred C57BL; Motor Skills; Prefrontal Cortex; Receptors, Metabotropic Glutamate; Synaptosomes; Xanthenes | 2021 |
Role of gambogenic acid in regulating PI3K/Akt/NF-kβ signaling pathways in rat model of acute hepatotoxicity.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Liver; Male; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Xanthenes | 2021 |
Austalide K from the Fungus
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Cell Differentiation; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression Regulation; Geologic Sediments; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Molecular Structure; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Osteoporosis; Penicillium; RANK Ligand; Tartrate-Resistant Acid Phosphatase; Xanthenes | 2021 |
mGlu2/3 receptor in the prelimbic cortex is implicated in stress resilience and vulnerability in mice.
Topics: Amino Acids; Animals; Depression; Disease Models, Animal; Humans; Male; Mice; Prefrontal Cortex; Receptors, Metabotropic Glutamate; Resilience, Psychological; Social Defeat; Stress, Psychological; Xanthenes | 2021 |
Xanthohumol Blocks Proliferation and Migration of Vascular Smooth Muscle Cells in Vitro and Reduces Neointima Formation in Vivo.
Topics: Animals; Becaplermin; Cell Movement; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonoids; Humulus; MAP Kinase Signaling System; Mice; Molecular Structure; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Oxazines; Phosphorylation; Platelet-Derived Growth Factor; Propiophenones; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Signal Transduction; Wound Healing; Xanthenes | 2017 |
Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
Topics: Animals; Disease Models, Animal; Disease Progression; G-Protein-Coupled Receptor Kinase 2; Heart Failure; Mice; Mice, Knockout; Myocardial Ischemia; Myocardium; Myofibroblasts; Ventricular Remodeling; Xanthenes | 2017 |
TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Amino Acids; Angiogenesis Inhibitors; Animals; Cell Line; Disease Models, Animal; Female; Fibroblasts; Humans; Male; Middle Aged; Neovascularization, Pathologic; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Xanthenes | 2018 |
Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Endothelium, Vascular; Enzyme Activators; Humans; Hypertension, Pulmonary; Imidazoles; Leucine; Lung; Male; Monocrotaline; Naphthalenes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Phosphorylation; Pulmonary Artery; Pyrans; Rats; Rats, Sprague-Dawley; Signal Transduction; Specific Pathogen-Free Organisms; Spiro Compounds; Xanthenes | 2017 |
Effect of streptozotocin-induced diabetes on motor representations in the motor cortex and corticospinal tract in rats.
Topics: Action Potentials; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; Electric Stimulation; Hindlimb; Ketosis; Male; Motor Cortex; Motor Disorders; Neural Conduction; Neurons; Pyramidal Tracts; Rats; Rats, Wistar; Xanthenes | 2018 |
Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine.
Topics: Analgesics, Opioid; Animals; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokines, CC; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Humans; Macrophage Inflammatory Proteins; Macrophages; Mice; Morphine Derivatives; Neuralgia; Neurons; Receptors, CCR1; Xanthenes | 2018 |
Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine.
Topics: Amino Acids; Analysis of Variance; Animals; Central Nervous System Stimulants; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Interactions; Excitatory Amino Acid Antagonists; Immobility Response, Tonic; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Swimming; Xanthenes | 2013 |
Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats.
Topics: Action Potentials; Affective Symptoms; Analysis of Variance; Aniline Compounds; Animals; Arginine; Corticotropin-Releasing Hormone; Cyclohexanes; Disease Models, Animal; Excitatory Amino Acid Antagonists; Formaldehyde; GABA Antagonists; Hormone Antagonists; Hormones; In Vitro Techniques; Kynurenic Acid; Male; Membrane Potentials; Microdialysis; Neurons; Neuropeptide Y; Pain; Pain Measurement; Peptide Fragments; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Xanthenes | 2013 |
Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats.
Topics: Amino Acids; Animals; Corticosterone; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Drug Administration Schedule; Immobility Response, Tonic; Injections, Subcutaneous; Ketamine; Male; Rats; Receptors, Metabotropic Glutamate; Xanthenes | 2013 |
The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
Topics: Analysis of Variance; Animals; Bone Neoplasms; Cell Line, Tumor; Chemokine CCL5; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Gene Expression Regulation, Neoplastic; Hyperalgesia; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Pain Measurement; Pain Threshold; Peptide T; Receptors, CCR1; Xanthenes | 2014 |
Gambogenic acid kills lung cancer cells through aberrant autophagy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Knockdown Techniques; HeLa Cells; Humans; Lung Neoplasms; Lysosomes; Male; Membrane Proteins; Mice; Phagosomes; Terpenes; Xanthenes; Xanthones; Xenograft Model Antitumor Assays | 2014 |
N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
Topics: Acetylcysteine; Action Potentials; Amino Acids; Amphetamines; Animals; Benzoates; Bicuculline; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Early Growth Response Protein 2; Excitatory Amino Acid Antagonists; Free Radical Scavengers; GABA-A Receptor Antagonists; Glycine; Hallucinations; Hallucinogens; Male; Mice; Proto-Oncogene Proteins c-fos; Receptors, Metabotropic Glutamate; Xanthenes | 2014 |
Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.
Topics: Adrenal Glands; Animals; Cells, Cultured; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; G-Protein-Coupled Receptor Kinase 2; Heart; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Stroke Volume; Treatment Outcome; Xanthenes | 2014 |
Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Topics: Adaptation, Psychological; Amino Acids; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Ketamine; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Stress, Psychological; Swimming; Time Factors; Xanthenes | 2014 |
Jacarelhyperol A induced apoptosis in leukaemia cancer cell through inhibition the activity of Bcl-2 proteins.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Binding Sites; Caspases; Cell Line, Tumor; Cytochromes c; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia; Mice; Models, Molecular; Molecular Conformation; Protein Binding; Protein Multimerization; Proto-Oncogene Proteins c-bcl-2; Xanthenes; Xenograft Model Antitumor Assays | 2014 |
Epigenetic upregulation of metabotropic glutamate receptor 2 in the spinal cord attenuates oestrogen-induced visceral hypersensitivity.
Topics: Acetylation; Amino Acids; Animals; Disease Models, Animal; Epigenesis, Genetic; Estradiol; Estrogens; Female; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Nociception; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; RNA, Messenger; Spinal Cord; Up-Regulation; Viscera; Visceral Pain; Vorinostat; Xanthenes | 2015 |
Investigating glutamatergic mechanism in attention and impulse control using rats in a modified 5-choice serial reaction time task.
Topics: Amino Acids; Animals; Attention; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Impulsive Behavior; Male; N-Methylaspartate; Prefrontal Cortex; Rats; Reaction Time; Xanthenes | 2014 |
Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model.
Topics: Analysis of Variance; Animals; Brain; Cholinesterase Inhibitors; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Membrane Potential, Mitochondrial; Mitochondria; Oxygen; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Xanthenes; Zinc | 2015 |
The Female Encounter Test: A Novel Method for Evaluating Reward-Seeking Behavior or Motivation in Mice.
Topics: Amino Acids; Animals; Antidepressive Agents, Second-Generation; Castration; Choice Behavior; Corticosterone; Depressive Disorder; Disease Models, Animal; Equipment Design; Estrous Cycle; Excitatory Amino Acid Antagonists; Female; Fluvoxamine; Lipopolysaccharides; Male; Mice; Motivation; Nucleus Accumbens; Psychological Tests; Reward; Social Behavior; Social Isolation; Xanthenes | 2015 |
The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Rotarod Performance Test; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Swimming; Xanthenes; Xanthones | 2015 |
Changes in T-Tubules and Sarcoplasmic Reticulum in Ventricular Myocytes in Early Cardiac Hypertrophy in a Pressure Overload Rat Model.
Topics: Aniline Compounds; Animals; Calcium; Calcium Signaling; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fluorescence Recovery After Photobleaching; Fluorescent Dyes; Ions; Male; Microscopy, Confocal; Microtubules; Myocytes, Cardiac; Pressure; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Xanthenes | 2015 |
Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Behavior, Animal; Benzamides; Diencephalon; Disease Models, Animal; Histone Deacetylase 1; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Indoles; Larva; Locomotion; Neurotoxins; Oxazines; Parkinson Disease, Secondary; Pyridines; RNA, Messenger; Tyrosine 3-Monooxygenase; Xanthenes; Zebrafish; Zebrafish Proteins | 2016 |
Involvement of CC Chemokine Receptor 1 and CCL3 in Acute and Chronic Inflammatory Pain in Mice.
Topics: Acute Pain; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Chemokine CCL3; Chemokine CCL5; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Freund's Adjuvant; Hyperalgesia; Inflammation; Male; Mice; Neutrophils; Receptors, CCR1; RNA, Messenger; Spinal Cord; Xanthenes | 2016 |
Immune malfunction in the GPR39 zinc receptor of knockout mice: Its relationship to depressive disorder.
Topics: Animals; Cell Proliferation; Cell Survival; Concanavalin A; Cytokines; Depressive Disorder; Disease Models, Animal; Female; Gene Expression Regulation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogens; Motor Activity; Organ Size; Oxazines; Receptors, G-Protein-Coupled; Spleen; Swimming; Thymocytes; Xanthenes | 2016 |
Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity.
Topics: Administration, Oral; Animals; Biomarkers; Biotransformation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Kinetics; Mice; Molecular Structure; Oxonic Acid; Structure-Activity Relationship; Uric Acid; Xanthenes; Xanthine Oxidase; Xanthones | 2016 |
Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Disease Models, Animal; Female; Gonorrhea; Humans; Indicators and Reagents; Mice, Inbred BALB C; Neisseria gonorrhoeae; Oxazines; Treatment Outcome; Xanthenes | 2016 |
Metabotropic glutamate receptor 2/3 density and its relation to the hippocampal neuropathology in a model of temporal lobe epilepsy in rats.
Topics: Acute Disease; Amino Acids; Animals; Autoradiography; Chronic Disease; Cross-Sectional Studies; Disease Models, Animal; Disease Progression; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; Hippocampus; Kainic Acid; Male; Parietal Lobe; Radiopharmaceuticals; Rats, Wistar; Receptors, Metabotropic Glutamate; Thalamus; Time Factors; Tritium; Xanthenes | 2016 |
Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Aniline Compounds; Animals; Atrial Remodeling; Calcium; Cardiomegaly; Cytoplasm; Disease Models, Animal; Endothelin-1; Fluorescent Dyes; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; Membrane Proteins; Muscular Dystrophy, Emery-Dreifuss; Myocardium; Myocytes, Cardiac; Nuclear Envelope; Nuclear Proteins; Phenylephrine; Primary Cell Culture; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Ventricular Remodeling; Xanthenes | 2017 |
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells.
Topics: Amino Acids; Animals; Bone Morphogenetic Protein Receptors; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glioma; Humans; Magnetic Resonance Imaging; Mice; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Phosphorylation; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes | 2008 |
Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa.
Topics: Aminoglycosides; Animals; Carrier Proteins; cis-trans-Isomerases; Codon, Nonsense; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroretinography; Eye Proteins; Fluorescent Dyes; Gentamicins; Mice; Mice, Mutant Strains; Rats; Rats, Transgenic; Retina; Retinitis Pigmentosa; Rhodopsin; Xanthenes | 2008 |
Repeated exposure to cocaine alters the modulation of mesocorticolimbic glutamate transmission by medial prefrontal cortex Group II metabotropic glutamate receptors.
Topics: Amino Acids; Animals; Cocaine; Cocaine-Related Disorders; Cystine; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Glutamic Acid; Limbic System; Male; Neural Pathways; Prefrontal Cortex; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission; Synaptic Vesicles; Ventral Tegmental Area; Xanthenes | 2008 |
Supraspinal Gbetagamma-dependent stimulation of PLCbeta originating from G inhibitory protein-mu opioid receptor-coupling is necessary for morphine induced acute hyperalgesia.
Topics: Animals; Cyclohexanes; Disease Models, Animal; Drug Administration Routes; Drug Interactions; Exploratory Behavior; Gene Expression Regulation; GTP-Binding Protein beta Subunits; Hyperalgesia; Immunoprecipitation; Male; Mice; Mice, Knockout; Morphine; Pain Measurement; Pain Threshold; Periaqueductal Gray; Phospholipase C beta; Reaction Time; Receptors, Opioid, mu; Somatostatin; Xanthenes | 2009 |
Polyethylene glycol rapidly restores axonal integrity and improves the rate of motor behavior recovery after sciatic nerve crush injury.
Topics: Action Potentials; Analysis of Variance; Animals; Axons; Disease Models, Animal; Locomotion; Male; Motor Activity; Neural Conduction; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Recovery of Function; Sciatic Neuropathy; Surface-Active Agents; Time Factors; Xanthenes | 2010 |
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
Topics: Amino Acids; Analysis of Variance; Animals; Bridged Bicyclo Compounds; Depression; Dicarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Hindlimb Suspension; Ketamine; Male; Mice; Mice, Inbred ICR; Receptors, Metabotropic Glutamate; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Xanthenes | 2011 |
Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice.
Topics: Animals; Animals, Outbred Strains; Cocaine; Cocaine-Related Disorders; Corpus Striatum; Cyclohexanes; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Female; Hyperkinesis; Male; Mice; Mice, Knockout; Nucleus Accumbens; Receptors, Neuropeptide Y; Reinforcement, Psychology; Self Administration; Xanthenes | 2012 |
The use of the microplate alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Histocytochemistry; Indicators and Reagents; Leprostatic Agents; Liver; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium Infections; Mycobacterium lepraemurium; Oxazines; Plant Extracts; Xanthenes | 2012 |
Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation.
Topics: Action Potentials; Amino Acid Sequence; Amino Acids; Animals; Capsaicin; Chromosome Mapping; Chromosomes, Mammalian; Dendrites; Disease Models, Animal; Exons; Eye Diseases, Hereditary; Genetic Diseases, X-Linked; Heterozygote; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation, Missense; Myopia; Night Blindness; Point Mutation; Retina; Retinal Bipolar Cells; Sequence Analysis, DNA; Threonine; TRPM Cation Channels; Xanthenes | 2012 |
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.
Topics: Acetamides; Amino Acid Sequence; Animals; Antitubercular Agents; Clofazimine; Diarylquinolines; Disease Models, Animal; Drug Discovery; Drugs, Investigational; Female; Genetic Engineering; Latent Tuberculosis; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium tuberculosis; Oxazines; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Structure-Activity Relationship; Xanthenes | 2012 |
Modafinil attenuates reinstatement of cocaine seeking: role for cystine-glutamate exchange and metabotropic glutamate receptors.
Topics: Amino Acid Transport System y+; Amino Acids; Analysis of Variance; Animals; Benzhydryl Compounds; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug-Seeking Behavior; Excitatory Amino Acid Antagonists; Extinction, Psychological; Glutamates; Male; Microdialysis; Microinjections; Modafinil; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Secondary Prevention; Self Administration; Wakefulness-Promoting Agents; Xanthenes | 2014 |
Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
Topics: Amino Acids; Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depressive Disorder; Disease Models, Animal; Excitatory Amino Acid Antagonists; Exploratory Behavior; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Receptor, trkB; Receptors, Metabotropic Glutamate; Signal Transduction; Xanthenes | 2013 |
1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Benzimidazoles; Carbocyanines; Coloring Agents; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluorometry; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Mitochondria; Nerve Tissue Proteins; Oxazines; Oxidation-Reduction; Parkinsonian Disorders; Piperazines; Presynaptic Terminals; Rats; Rats, Wistar; Sodium Cyanide; Synaptosomes; Tyrosine 3-Monooxygenase; Xanthenes | 2003 |
Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Analysis of Variance; Animals; Area Under Curve; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Humans; Hyperkinesis; In Vitro Techniques; Ketamine; Male; Microdialysis; Motor Activity; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Metabotropic Glutamate; Schizophrenia; Serotonin; Sulfur Isotopes; Time Factors; Trifluoroethanol; Xanthenes | 2003 |
Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats.
Topics: Animals; Biomarkers; Catalysis; Disease Models, Animal; Endothelium, Vascular; Endotoxemia; Enzyme Inhibitors; Fluorescent Dyes; Guanidines; I-kappa B Proteins; Leukocytes; Metalloporphyrins; Models, Cardiovascular; Myocarditis; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine; Xanthenes | 2004 |
Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.
Topics: Amino Acids; Analgesics; Animals; Behavior, Animal; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Humans; Immunohistochemistry; Injections, Intravenous; Injections, Spinal; Nociceptors; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Protease Inhibitors; Proto-Oncogene Proteins c-fos; Rats; Reaction Time; Sciatic Neuropathy; Urea; Xanthenes | 2004 |
Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms.
Topics: Adenosine Triphosphatases; Alkaloids; Analysis of Variance; Aniline Compounds; Animals; Behavior, Animal; Brain Chemistry; Calcium; Carbohydrates; Cell Count; Cell Death; Cell Line; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Escape Reaction; Glutathione Peroxidase; Hippocampus; Humans; Male; Mannans; Maze Learning; Memory Disorders; Muscarinic Antagonists; Neuroprotective Agents; Oligosaccharides; Rats; Rats, Wistar; Reaction Time; Scopolamine; Sesquiterpenes; Superoxide Dismutase; Swimming; Time Factors; Xanthenes | 2005 |
Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Topics: Animals; Cells, Cultured; Convulsants; Cyclohexanes; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Hippocampus; Kainic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neurons; Neuropeptide Y; Organ Culture Techniques; Receptors, Neuropeptide Y; Synaptic Transmission; Xanthenes | 2005 |
The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.
Topics: Age Factors; Amino Acids; Analysis of Variance; Animals; Baclofen; Behavior, Animal; Blotting, Western; Brain; Brain Mapping; Circadian Rhythm; Cyclic AMP; Disease Models, Animal; Electroencephalography; Epilepsy, Absence; Excitatory Amino Acid Antagonists; GABA Agonists; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indoles; Male; Microdialysis; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Metabotropic Glutamate; Xanthenes | 2005 |
Neuroprotective effect of N-acetyl-aspartyl-glutamate in combination with mild hypothermia in the endothelin-1 rat model of focal cerebral ischaemia.
Topics: Amino Acids; Animals; Blood-Brain Barrier; Brain Ischemia; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Endothelin-1; Hypothermia; Male; Microdialysis; Neuroprotective Agents; Rats; Rats, Wistar; Time Factors; Xanthenes | 2005 |
Alcohol potently modulates climbing fiber-->Purkinje neuron synapses: role of metabotropic glutamate receptors.
Topics: Alanine; Animals; Aspartic Acid; Disease Models, Animal; Ethanol; Long-Term Synaptic Depression; Male; Nerve Fibers; Patch-Clamp Techniques; Purkinje Cells; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synapses; Xanthenes | 2006 |
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
Topics: Amino Acids; Amphetamine; Animals; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cyclic S-Oxides; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mental Disorders; Mice; Molecular Structure; Motor Activity; Phencyclidine; Prefrontal Cortex; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Xanthenes | 2007 |
Angiotensin-converting enzyme inhibitor improves force and Ca2 +--frequency relationships in myocytes from rats with heart failure.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aniline Compounds; Animals; Blotting, Western; Calcium-Binding Proteins; Disease Models, Animal; Fluorescent Dyes; Heart Failure; Heart Ventricles; Male; Microscopy, Confocal; Myocardial Contraction; Myocytes, Cardiac; Perindopril; Random Allocation; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger; Xanthenes | 2007 |
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?
Topics: Adjuvants, Pharmaceutic; Amino Acids; Animals; Antidepressive Agents, Tricyclic; Bridged Bicyclo Compounds, Heterocyclic; Depressive Disorder; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Agents; Hippocampus; Imipramine; In Vitro Techniques; Mice; Neurons; Rats; Rats, Inbred Strains; Receptor Cross-Talk; Receptors, Metabotropic Glutamate; Time Factors; Xanthenes | 2007 |
Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Amino Acids; Analysis of Variance; Animals; Behavior, Animal; Cell Line, Transformed; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Fluid; Female; Free Radical Scavengers; Glutamic Acid; Glycine; Humans; Interpersonal Relations; Male; Maze Learning; Microdialysis; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia; Xanthenes | 2008 |
Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme Activators; Heart; Hypertension; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resorcinols; Structure-Activity Relationship; Xanthenes | 2008 |
Generation and control of metastasis in experimental tumor systems; inhibition of experimental metastases by a tilorone analogue.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; G(M1) Ganglioside; Immune Sera; Killer Cells, Natural; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Spleen; Tilorone; Time Factors; Xanthenes; Xanthones | 1993 |
New antidiabetic compounds, mangiferin and its glucoside.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hyperinsulinism; Hypoglycemic Agents; Male; Mice; Xanthenes; Xanthones | 1998 |
Free radical production correlates with cell death in an in vitro model of epilepsy.
Topics: Action Potentials; Aniline Compounds; Animals; Antioxidants; Bicuculline; Calcium; Cell Death; Disease Models, Animal; Epilepsy; Fluorescent Dyes; Free Radicals; GABA Antagonists; Glutathione; Hippocampus; Microscopy, Fluorescence; Nerve Degeneration; Organ Culture Techniques; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Rhodamines; Vitamin E; Xanthenes | 2000 |
Antidiabetic activity of a xanthone compound, mangiferin.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Magnoliopsida; Male; Mice; Phytotherapy; Plant Extracts; Xanthenes; Xanthones | 2001 |
Upregulation of extracellular ATP-induced Müller cell responses in a dispase model of proliferative vitreoretinopathy.
Topics: Adenosine Triphosphate; Aniline Compounds; Animals; Calcium; Disease Models, Animal; Endopeptidases; Female; Hypertrophy; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Microscopy, Confocal; Neuroglia; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Rabbits; Receptors, Purinergic P2; Up-Regulation; Vitreoretinopathy, Proliferative; Xanthenes | 2002 |
Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
Topics: Amino Acids; Animals; Animals, Newborn; Brain; Carboxypeptidases; Cyclic AMP; Cycloleucine; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Hippocampus; Hypoxia-Ischemia, Brain; Neurons; Neuroprotective Agents; Organophosphorus Compounds; Propionates; Rats; Rats, Sprague-Dawley; Xanthenes | 2002 |
[Pathophysiological and toxicological aspects of Schistosoma mansoni infection in Mastomys natalensis under treatment with Hycanthone].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Female; Glutamate Dehydrogenase; L-Lactate Dehydrogenase; Liver Diseases; Male; Mesylates; Mice; Mice, Inbred Strains; Oxidoreductases; Parasite Egg Count; Schistosoma; Schistosomiasis; Sorbitol; Xanthenes | 1973 |